AI-driven platform captures and summarizes doctor-patient conversations, offering transcriptions and key insights.
You can scroll over the chart's area to move in time and tap to see a specific date.
Highest Bid
$ 260.80
Lowest Offer
$ 188.50
Last Trade
$ 234.00
Live Orders
1,298
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Abridge offers an AI-powered platform that helps users capture and summarize important information during healthcare conversations. The company focuses on providing tools that automatically transcribe and highlight key points from doctor-patient interactions, ensuring patients can easily review and retain critical health information.
Abridge Funding
Sign up to gain insights into Abridge funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series E | Jun 24, 2025 | 300M | ||
| Series D | Feb 17, 2025 | 250M | ||
| Series C | Feb 22, 2024 | 141M | ||
| Series B | Oct 26, 2023 | 30M | ||
| Series A | Aug 11, 2022 | 13M | ||
| Series A | Mar 26, 2020 | 10M | ||
| Series Seed | Jan 31, 2019 | 5M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Abridge Management Team
Investors
Wittington Ventures
Whistler Capital Partners
UPMC Enterprises
Union Square Ventures
Pillar Companies
KdT Ventures
Bessemer Venture Partners
Abridge Valuations & Financials
View real-time NPM data on Abridge stock including daily Abridge stock price estimates, valuation history, and historical share price information. Access Abridge financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Abridge pricing across six independent market signals. Looking for private company due diligence data sources on Abridge? Get in touch to learn more.
Similar Companies
like Abridge
Scale
AI & Machine Learning
Generative AI platform leveraging enterprise data and foundation models for businesses.
Zipline
AI & Machine Learning
Designs, manufactures, and operates small robot aircrafts to deliver essential medical products.
Lightmatter
AI & Machine Learning
Develops AI compute technologies that accelerate AI growth.
Dexterity
AI & Machine Learning
Specializes in automating warehouse operations using advanced AI to empower robots for complex tasks traditionally done by humans.
Dataiku
AI & Machine Learning
Operates a leading AI and machine learning platform for organizations' data efforts.
Checkr
AI & Machine Learning
Provides fast and compliant background screenings for companies, with options to manage screenings through an API or web dashboard.
FAQ
We have answers
Abridge stock does not trade on public stock exchanges. Abridge stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Abridge stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Abridge Stock does not trade on public stock exchanges. In order to sell Abridge shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Nasdaq Private Market estimates that Abridge price per share was $175.96 as of July 13, 2026. This Abridge share value estimate (known as the NPM price) is based on market activity, publicly-sourced valuation data, and other proprietary information. With NPM Data and Intelligence premium for investors, you can get visibility into the Abridge share price today and the factors driving Abridge valuation estimates. Learn more about premium data here.
Read more about private company stock prices: Understanding the Bid-Ask Spread: How Buyers and Sellers Match on Price
There is no ticker symbol for Abridge stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Abridge stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Abridge stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Abridge is a private company and has not had an IPO. There is currently no Abridge IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Abridge IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
